Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DN.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DN.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DJ.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DJ.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DJ.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DJ.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBC.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBC.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CM.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CM.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BW.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BW.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BW.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BW.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.10.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.10.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.10.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.10.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FW.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FW.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FW.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FW.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CH.1.1.29ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CH.1.1.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.29NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.55ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.55ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.55ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.55NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.14ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.14NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.35ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.35ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.35NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used